Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:01 pm Sale |
2024-09-30 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Armistice Capital, LLC | 0 0.000% |
-5,200,000 (Position Closed) |
Filing History |
| 2024-02-14 4:26 pm Purchase |
2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Redmile Group LLC | 8,359,768 9.900% |
1,251,671 (+17.61%) |
Filing History |
| 2024-02-14 4:06 pm Sale |
2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
BRAIDWELL LP | 2,385,623 2.920% |
-2,213,861 (-48.13%) |
Filing History |
| 2024-02-14 2:26 pm Purchase |
2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Armistice Capital, LLC | 5,200,000 6.490% |
28,000 (+0.54%) |
Filing History |
| 2024-02-13 5:02 pm Sale |
2023-12-29 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
The Vanguard Group | 4,401,636 5.490% |
-343,685 (-7.24%) |
Filing History |
| 2024-02-12 5:32 pm Purchase |
2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Flynn James E | 5,788,024 7.190% |
1,160,714 (+25.08%) |
Filing History |
| 2024-02-09 4:30 pm Sale |
2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Brightstar Associates LLC | 23,059,708 28.200% |
-48,136 (-0.21%) |
Filing History |
| 2024-02-06 4:52 pm Sale |
2023-12-29 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
GOLDMAN SACHS GROUP INC GS |
2,007,447 2.500% |
-1,828,712 (-47.67%) |
Filing History |
| 2024-01-26 11:49 am Purchase |
2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
BLACKROCK INC BLK |
5,976,266 7.500% |
556,241 (+10.26%) |
Filing History |
| 2024-01-23 09:45 am Sale |
2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
STATE STREET CORP STT |
2,470,813 3.080% |
-977,211 (-28.34%) |
Filing History |
| 2023-03-22 4:17 pm Purchase |
2023-03-13 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Flynn James E | 4,627,310 6.090% |
2,278,082 (+96.97%) |
Filing History |
| 2023-02-14 4:19 pm Purchase |
2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Redmile Group LLC | 7,108,097 9.900% |
1,427,180 (+25.12%) |
Filing History |
| 2023-02-14 4:06 pm Purchase |
2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
BRAIDWELL LP | 4,599,484 6.680% |
4,599,484 (New Position) |
Filing History |
| 2023-02-14 12:32 pm Purchase |
2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Armistice Capital, LLC | 5,172,000 7.650% |
1,741,846 (+50.78%) |
Filing History |
| 2023-02-14 09:12 am Sale |
2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
BANK OF AMERICA CORP BAC |
302,410 0.400% |
-2,722,903 (-90.00%) |
Filing History |
| 2023-02-10 09:42 am Sale |
2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Flynn James E | 2,349,228 3.480% |
-3,231,228 (-57.90%) |
Filing History |
| 2023-02-09 11:16 am Purchase |
2022-12-30 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
The Vanguard Group | 4,745,321 7.020% |
1,276,004 (+36.78%) |
Filing History |
| 2023-02-08 4:16 pm Purchase |
2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Brightstar Associates LLC | 23,107,844 28.200% |
6,535,474 (+39.44%) |
Filing History |
| 2023-02-08 09:52 am Purchase |
2022-12-30 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
GOLDMAN SACHS GROUP INC GS |
3,836,159 5.700% |
212,914 (+5.88%) |
Filing History |
| 2023-02-03 4:27 pm Purchase |
2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
BLACKROCK INC BLK |
5,420,025 8.000% |
1,622,456 (+42.72%) |
Filing History |